Delivery Order SPE2DB22D1106-SPE2DB25FERE3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,133.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $6,052.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 24, 2025, for Phenobarbital 65 mg/mL vials valued at $1,290.04 under a Firm Fixed Price contract type. The award, issued by the Medical Supply Chain division of the Defense Logistics Agency, requires performance at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 25, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Phenobarbital 130mg/ml in quantities of 25 units. This firm fixed-price delivery order, valued at $2,896.34, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by May 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work...
- This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on July 23, 2025, covers the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,455.30. The contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Phenobarbital 130 mg/ml vials, with a contract ceiling value of $8,976.00 and an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $2,562.39 to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,281.64. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and was competitively awarded without any set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERE3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Phenobarbital 130 mg/mL vials under a firm fixed-price contract. This award, valued at $1,287.42, represents a competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle. Phenobarbital, a barbiturate medication with neurological applications, is among the diverse pharmaceutical portfolio the contractor supplies through its DLA relationships. The company's track record of competitive awards across multiple therapeutic domains, combined with its established prime vendor status, positions it as a key supplier for military and veteran healthcare medical supply chains. The ultimate completion date for this delivery order is June 3, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/2/25 |